针对细菌和原生病原体的向参与:用于药物发现的体外和细胞分析
Priscila Z Ramos1, Carolina M C Catta-Preta2, Rafael M Couñago3
1Centro de Química Medicinal (CQMED), Centro de Biologia Molecular e Engenharia Genética (CBMEG), Universidade Estadual de Campinas, UNICAMP, 13083-886, Campinas, SP, Brazil.
Current opinion in structural biology
|November 29, 2025
概括
目标参与 (TE) 试验对于药物发现至关重要,但对病原体具有挑战性. 新兴的工具有望通过改善对药物相互作用的理解来推进抗感染疗法.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 目标参与 (TE) 试验对于人类药物发现至关重要.
- 它们对细菌和原生病原体的应用受到复杂性和技术障碍的限制.
研究的目的:
- 审查当前对病原体研究的TE策略.
- 突出新兴的工具,以评估药物向相互作用在传染病.
主要方法:
- 关于TE测试方法的文献综述.
- 讨论新的技术,如生物发光共振能量转移,细胞热转移试验和化学保护体学.
主要成果:
- 目前的TE测定在病原体研究中面临重大局限性.
- 新兴技术为克服这些障碍提供了有希望的解决方案.
结论:
- 在病原体研究中扩大TE测试应用是至关重要的.
- 这将增强机械洞察力,减少开发风险,并导致更好的抗感染药物.
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K


